Weipeng Wang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Cell Cycle Arrest

Metastatic Colorectal Cancer

Top Venues

Cancer immunology, immunotherapy : CII

Journal of immunology research

Investigational new drugs

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yuling Sun, Jie Yang, Yachun Chen, Yundi Guo, Jian Xiong, Xuqin Guo, Yawen Zhang, Li Gu, Min Tong, Weipeng Wang, Jing Sun
PD-L2 Expression in Breast Cancer Promotes Tumor Development and Progression. Journal of immunology research 2024 (2024)
Yuling Sun, Jie Yang, Yachun Chen, Yundi Guo, Jian Xiong, Xuqin Guo, Yawen Zhang, Li Gu, Min Tong, Weipeng Wang, Jing Sun
PD-L2 Expression in Breast Cancer Promotes Tumor Development and Progression. Journal of immunology research 2024 (2024)
Mengmeng Wang, Zhoudong Zhang, Mengxi Chen, Yixin Lv, Sheng Tian, Fanyi Meng, Yawen Zhang, Xuqin Guo, Yinshuang Chen, Man Yang, Jiawei Li, Tian Qiu, Fang Xu, Zhi Li, Qi Zhang, Jie Yang, Jing Sun, Hongjian Zhang, Haiyang Zhang, Huanqiu Li, Weipeng Wang
FDW028, a novel FUT8 inhibitor, impels lysosomal proteolysis of B7-H3 via chaperone-mediated autophagy pathway and exhibits potent efficacy against metastatic colorectal cancer. Cell death & disease 14 (8) (2023)
Fanyi Meng, Jiawei Li, Yajing Qiu, Haiyang Zhang, Hongjian Zhang, Weipeng Wang
AM22, a novel synthetic microRNA, inhibits the proliferation of colorectal cancer cells by targeting core binding factor subunit β (CBFB). Investigational new drugs 40 (3) (2022)
Yawen Zhang, Mengmeng Wang, Fanyi Meng, Man Yang, Yinshuang Chen, Xuqin Guo, Weiwei Wang, Yifan Zhu, Yundi Guo, Chunlai Feng, Shen Tian, Hongjian Zhang, Huanqiu Li, Jing Sun, Weipeng Wang
A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3/DHCR24/ROS axis. Cell death discovery 8 (1) (2022)
Fanyi Meng, Man Yang, Yinshuang Chen, Weichang Chen, Weipeng Wang
miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis. Cancer immunology, immunotherapy : CII 70 (8) (2021)
Fanyi Meng, Yinshuang Chen, Man Yang, Hongjian Zhang, Weipeng Wang
Concomitant inhibition of B7-H3 and PD-L1 expression by a novel and synthetic microRNA delivers potent antitumor activities in colorectal tumor models. Investigational new drugs 39 (5) (2021)
Chunxia Zhang, Yinshuang Chen, Fuchao Li, Man Yang, Fanyi Meng, Yawen Zhang, Weichang Chen, Weipeng Wang
B7-H3 is spliced by SRSF3 in colorectal cancer. Cancer immunology, immunotherapy : CII 70 (2) (2020)